TRIM24, for instance, is overexpressed in breast cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, glioma, gastric cancer, bladder cancer and hepatocellular carcinoma [250,251,252,253,254,255,256]. Here, TRIM24 is linked to hepatocellular carcinoma.